Crossmark

Analytical method development and validation for simultaneous estimation of Fimasartan Potassium Trihydrate and Cilnidipine in synthetic mixture by HPLC for the treatment of hypertension stage-II

Crossref DOI link: https://doi.org/10.1186/s43094-021-00336-x

Published Online: 2021-09-16

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sojitra, Radhika G. http://orcid.org/0000-0002-9393-8270
Chotaliya, Urvi J.
License Information

Text and Data Mining valid from 2021-09-16

Version of Record valid from 2021-09-16
More Information

Article History

Received: 28 May 2021

Accepted: 28 August 2021

First Online: 16 September 2021

Declarations

:

: Not applicable.

: Not applicable.

: The data for verification is provided with a Supplementary file and the rest of the data, if required, will be available upon request.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below